India to Thailand: Insulin Export Trade Route

The India to Thailand Insulin corridor is one of India's established pharmaceutical export routes, with 367 shipments documented worth a combined $21.7M USD. The route is dominated by WOCKHARDT LIMITED, which alone accounts for roughly 41% of all export value, reflecting the consolidated nature of India's insulin manufacturing sector.

Across 6 active suppliers, the average shipment value stands at $59.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with insulin's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 31 days port-to-port. The route has recorded an annual growth rate of 24.7%, placing it at rank #6 among India's top insulin export destinations globally.

On the import side, key buyers of Indian insulin in Thailand include BERLIN PHARMACEUTICALS INDUSTRY CO, BJC HEALTHCARE COMPANY LIMITED, BERLIN PHARMACEUTICALS INDUSTRY CO. and 13 others. BERLIN PHARMACEUTICALS INDUSTRY CO is the single largest importer with 78 shipments valued at $4.9M USD.

India's insulin exports to Thailand are driven primarily by a handful of large-scale manufacturers. WOCKHARDT LIMITED with 157 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — buyers in Thailand benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — WOCKHARDT LIMITED, WOCKHARDT LIMITED , M. J. BIOPHARM PRIVATE LIMITED — together account for 83% of total trade value on this route. The average shipment value of $59.2K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as winsulin 30/70 100iu 10ml vial -green ca and winsulin 30/70 100iu# 5x3ml cartridge, suggesting that buyers in Thailand tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, BERLIN PHARMACEUTICALS INDUSTRY CO is the largest importer with 78 shipments worth $4.9M USD — representing 22% of all insulin imports from India on this route. A total of 16 buyers are active on this corridor.